ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 706,930 | $1,435,068 | 1.29% |
| Western Standard LLC | 630,191 | $1,279,288 | 1.10% |
| Newtyn Management, LLC | 313,200 | $635,796 | 0.15% |
| Murchinson Ltd. | 50,593 | $102,704 | 0.01% |
| Tekla Capital Management LLC | 32,461 | $65,896 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $95,304 | 0.00% |
| OSAIC HOLDINGS, INC. | 57 | $115 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 42,502 | $86,279 | 0.00% |
| Parallel Advisors, LLC | 244 | $495 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 31 | $63 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 500 | $1,015 | 0.00% |
| WELLS FARGO & COMPANY/MN | 104 | $211 | 0.00% |
| NORTHERN TRUST CORP | 20,982 | $42,593 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 155,635 | $315,939 | 0.00% |
| STATE STREET CORP | 71,637 | $145,423 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 14,988 | $30,426 | 0.00% |
| BlackRock Inc. | 231,959 | $470,876 | 0.00% |
| Citadel Advisors | 14,100 | $28,623 | 0.00% |
| Citadel Advisors | 1,541 | $3,128 | 0.00% |
External links
This page lists ARCA BIOPHARMA INC's shareholders in Q2 2023. To view ARCA BIOPHARMA INC's shareholder history, click here.